SOLIX is the breakthrough technology optometrists need to elevate patient care and stay ahead of the competition. Built on high-speed Spectral Domain OCT, the FullRange® platform equips your clinic to identify and manage a broad spectrum of eye conditions, from the cornea to the retina. With SOLIX, you’ll deliver faster, more accurate diagnoses and offer a superior patient experience—setting your clinic apart.
The Optovue Solix empowers optometrists to pinpoint retinal abnormalities detected on fundus photography—including wide field images—and instantly view detailed cross sections with OCT. With expanded 6 mm by 6 mm optic nerve scans, your clinic gains higher image density and sharper, more reliable diagnostic data.
The advanced topography module delivers the precise corneal measurements optometrists need for accurate contact lens fitting and refractive surgery planning. Detect early keratoconus with confidence, thanks to detailed epithelial analysis. Perform comprehensive anterior and posterior corneal assessments, distinguishing epithelial cells and stroma, and monitor healing and refractive outcomes—all from a single scan.
Customizable reports with up to 6 simultaneous maps give you the insights to make smarter clinical decisions and impress your patients with technology that delivers results.
Maximize clinical utility
Optovue Solix is the next-generation solution for optometry clinics ready to lead in eye care. With FullRange® OCT and OCT-Angiography, a powerful integrated fundus camera, and external IR imaging, Solix offers the imaging versatility and precision your clinic needs. Its blazing-fast 120kHz scan speed, dense scan patterns, and advanced reporting features mean you diagnose more confidently, treat more proactively, and provide the highest level of care to your patients.
Glaucoma Detection

The Optovue Solix takes glaucoma detection to the next level with its advanced imaging and analytic capabilities. By incorporating sophisticated tools such as Dual Track, SSADA, MCT, and AI segmentation, the device provides a comprehensive approach to glaucoma assessment.
These technologies enable Solix to deliver exceptional reproducibility and repeatability, with performance that is twice as effective as previous models. This ensures reliable tracking of disease progression and treatment response. The integrated imaging features enable detailed visualization of structural and vascular changes associated with glaucoma, providing a holistic view of the condition.
Quantitative measurement tools enable precise assessment of the irido-corneal angle, trabecular meshwork, and Schlemm’s canal, facilitating early detection and ongoing management of glaucoma. This advanced diagnostic capability empowers clinicians to make well-informed decisions.
FullRange® Retina

The FullRange® Retina feature of the Optovue Solix provides unparalleled imaging and analysis capabilities, even for patients with high myopia. The device generates all necessary images and data for a comprehensive retinal evaluation, ensuring that no detail is overlooked.
The AngioVue OCTA technology offers precise visualization and quantification of the retinal vasculature, which is crucial for diagnosing and monitoring a variety of retinal conditions. The Quad-Montage feature combines multiple scans for widefield visualization of the peripheral retina, enabling detailed examination of retinal pathologies.
Additionally, the 3D OCTA rendering enables visualization of vascular connectivity, providing insights into complex vascular networks. These comprehensive imaging capabilities enhance the ability to diagnose, monitor, and treat retinal diseases.
Wellness and AngioWellness

The Wellness and AngioWellness features of the Optovue Solix represent a new standard in patient care, particularly for those with suspected retinal pathologies and glaucoma. These capabilities streamline the exam process by integrating structural and vascular assessments into a single, comprehensive report.
The AngioWellness scan provides a thorough evaluation of diabetic patients and glaucoma suspects by combining metrics on retinal and ganglion cell thickness with objective assessments of retinal vasculature. This holistic approach uncovers early indicators of diabetic changes and aids in the early detection and management of glaucoma. By offering a detailed overview of the patient’s ocular health, these wellness protocols improve patient involvement, retention, and practice differentiation.
Referencia

































